TEX9
geneOn this page
Summary
TEX9 (testis expressed 9, HGNC:29585) is a protein-coding gene on chromosome 15q21.3, encoding Testis-expressed protein 9 (Q8N6V9).
Located in centriolar satellite.
Source: NCBI Gene 374618 — RefSeq curated summary.
At a glance
- GWAS associations: 24
- Clinical variants (ClinVar): 83 total
- MANE Select transcript:
NM_001395496
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29585 |
| Approved symbol | TEX9 |
| Name | testis expressed 9 |
| Location | 15q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000151575 |
| Ensembl biotype | protein_coding |
| OMIM | 620935 |
| Entrez | 374618 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 12 protein_coding, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000352903, ENST00000537232, ENST00000558083, ENST00000558127, ENST00000559142, ENST00000559546, ENST00000560582, ENST00000560827, ENST00000561221, ENST00000696102, ENST00000876251, ENST00000876252, ENST00000876253, ENST00000931689, ENST00000931690, ENST00000956901, ENST00000956902
RefSeq mRNA: 16 — MANE Select: NM_001395496
NM_001286449, NM_001385040, NM_001385041, NM_001385042, NM_001385043, NM_001385044, NM_001385045, NM_001385046, NM_001385047, NM_001385048, NM_001385049, NM_001385050, NM_001385051, NM_001385052, NM_001395496, NM_198524
CCDS: CCDS10157, CCDS66776
Canonical transcript exons
ENST00000696102 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001103352 | 56389318 | 56389400 |
| ENSE00001183753 | 56388472 | 56388520 |
| ENSE00002548195 | 56391243 | 56391418 |
| ENSE00003965995 | 56412302 | 56412436 |
| ENSE00003965997 | 56428367 | 56430154 |
| ENSE00003965998 | 56365426 | 56365477 |
| ENSE00003965999 | 56383952 | 56384031 |
| ENSE00003966000 | 56427605 | 56427739 |
| ENSE00003966002 | 56365579 | 56365670 |
| ENSE00003966003 | 56373441 | 56373504 |
| ENSE00003966005 | 56394661 | 56394834 |
| ENSE00003966006 | 56394165 | 56394247 |
Expression profiles
Bgee: expression breadth ubiquitous, 192 present calls, max score 94.91.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.5030 / max 161.5657, expressed in 1266 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 146789 | 5.0356 | 1246 |
| 146790 | 0.1698 | 53 |
| 146793 | 0.1489 | 64 |
| 146791 | 0.0813 | 35 |
| 146792 | 0.0674 | 28 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 94.91 | gold quality |
| right uterine tube | UBERON:0001302 | 94.01 | gold quality |
| bronchial epithelial cell | CL:0002328 | 93.25 | gold quality |
| bronchus | UBERON:0002185 | 91.58 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 89.62 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.48 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.24 | gold quality |
| ventricular zone | UBERON:0003053 | 84.74 | gold quality |
| oocyte | CL:0000023 | 83.72 | gold quality |
| adenohypophysis | UBERON:0002196 | 83.20 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 83.14 | gold quality |
| ganglionic eminence | UBERON:0004023 | 82.82 | gold quality |
| secondary oocyte | CL:0000655 | 81.63 | gold quality |
| pituitary gland | UBERON:0000007 | 81.44 | gold quality |
| right testis | UBERON:0004534 | 81.40 | gold quality |
| left testis | UBERON:0004533 | 81.10 | gold quality |
| testis | UBERON:0000473 | 80.80 | gold quality |
| fallopian tube | UBERON:0003889 | 80.39 | gold quality |
| metanephros cortex | UBERON:0010533 | 79.86 | gold quality |
| islet of Langerhans | UBERON:0000006 | 79.39 | gold quality |
| minor salivary gland | UBERON:0001830 | 78.94 | gold quality |
| oviduct epithelium | UBERON:0004804 | 78.93 | gold quality |
| bone marrow cell | CL:0002092 | 77.26 | gold quality |
| adrenal tissue | UBERON:0018303 | 76.97 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 76.82 | gold quality |
| rectum | UBERON:0001052 | 76.81 | gold quality |
| thyroid gland | UBERON:0002046 | 76.71 | gold quality |
| gall bladder | UBERON:0002110 | 76.65 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 76.40 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 76.26 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.64 |
| E-MTAB-6058 | no | 296.66 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
26 targeting TEX9, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-4639-5P | 99.81 | 67.37 | 1028 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-7150 | 99.62 | 66.80 | 1322 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-5701 | 98.97 | 69.54 | 1502 |
| HSA-MIR-9903 | 98.47 | 66.70 | 748 |
| HSA-MIR-1199-5P | 98.44 | 66.51 | 829 |
| HSA-MIR-6751-3P | 98.44 | 66.35 | 835 |
| HSA-MIR-640 | 98.44 | 66.93 | 644 |
| HSA-MIR-6516-5P | 98.42 | 70.19 | 1551 |
| HSA-MIR-561-5P | 98.25 | 68.13 | 1365 |
| HSA-MIR-6880-5P | 98.08 | 65.59 | 1282 |
| HSA-MIR-4736 | 97.96 | 65.89 | 1287 |
| HSA-MIR-3921 | 97.81 | 67.45 | 1431 |
| HSA-MIR-3665 | 97.73 | 65.08 | 975 |
| HSA-MIR-562 | 97.66 | 65.63 | 698 |
| HSA-MIR-4670-3P | 97.37 | 68.35 | 1378 |
| HSA-MIR-4653-5P | 97.22 | 67.72 | 1429 |
| HSA-MIR-125A-3P | 97.04 | 66.92 | 902 |
| HSA-MIR-345-5P | 96.40 | 66.43 | 663 |
| HSA-MIR-644A | 96.02 | 66.52 | 786 |
Literature-anchored findings (GeneRIF, showing 1)
- Testis-expressed protein 9 (TEX9) expression is positively associated with eukaryotic translation initiation factor 3 subunit b (eIF3b) expression in esophageal squamous cell carcinoma (ESCC). TEX9 expression is positively correlated with tumor-node-metastasis stage in ESCC. eIF3b binding to TEX9 mRNA functionally synergizes to promote the proliferation and migration, and inhibit the apoptosis of ESCC cells. (PMID:31481019)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tex9 | ENSDARG00000010586 |
| mus_musculus | Tex9 | ENSMUSG00000090626 |
| rattus_norvegicus | Tex9 | ENSRNOG00000059702 |
| drosophila_melanogaster | CG4681 | FBGN0069913 |
Protein
Protein identifiers
Testis-expressed protein 9 — Q8N6V9 (reviewed: Q8N6V9)
All UniProt accessions (9): Q8N6V9, A0A0S2Z5Z9, A0A0S2Z669, A0A0S2Z6S1, H0YKG1, H0YLZ3, H0YM20, H0YND2, H3BS88
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Centriolar satellite.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N6V9-1 | 1 | yes |
| Q8N6V9-2 | 2 |
RefSeq proteins (16): NP_001273378, NP_001371969, NP_001371970, NP_001371971, NP_001371972, NP_001371973, NP_001371974, NP_001371975, NP_001371976, NP_001371977, NP_001371978, NP_001371979, NP_001371980, NP_001371981, NP_001382425, NP_940926 (=MANE)
Domains & families (InterPro)
UniProt features (5 total): region of interest 2, chain 1, coiled-coil region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N6V9-F1 | 78.74 | 0.54 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 106 (showing top):
SHEPARD_BMYB_MORPHOLINO_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GOCC_MICROTUBULE_ORGANIZING_CENTER, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOCC_CENTROSOME, TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP, RFX1_02, GATA4_Q3, GOCC_CENTRIOLAR_SATELLITE, MATSUDA_NATURAL_KILLER_DIFFERENTIATION, BRUINS_UVC_RESPONSE_LATE, ESC_V6.5_UP_EARLY.V1_UP, GSE14415_INDUCED_VS_NATURAL_TREG_DN, BANP_TARGET_GENES, DYRK1A_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): centriolar satellite (GO:0034451), cytoplasm (GO:0005737), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| binding | 1 |
| centrosome | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
470 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TEX9 | CCDC112 | Q8NEF3 | 584 |
| TEX9 | C10orf88 | Q9H8K7 | 556 |
| TEX9 | CCDC60 | Q8IWA6 | 543 |
| TEX9 | FAXC | Q5TGI0 | 542 |
| TEX9 | CCDC14 | Q49A88 | 490 |
| TEX9 | UTP3 | Q9NQZ2 | 485 |
| TEX9 | SPAG17 | Q6Q759 | 479 |
| TEX9 | TEX19 | Q8NA77 | 447 |
| TEX9 | CCDC13 | Q8IYE1 | 441 |
| TEX9 | SPATA4 | Q8NEY3 | 438 |
| TEX9 | KIAA0753 | Q2KHM9 | 436 |
| TEX9 | TEX26 | Q8N6G2 | 435 |
| TEX9 | SPATC1L | Q9H0A9 | 434 |
| TEX9 | BIVM | Q86UB2 | 424 |
| TEX9 | TEX22 | C9J3V5 | 418 |
IntAct
46 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KDM1A | TEX9 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TEX9 | CCDC112 | psi-mi:“MI:0915”(physical association) | 0.630 |
| CCDC112 | TEX9 | psi-mi:“MI:0915”(physical association) | 0.630 |
| TEX9 | GOLGA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOL4 | TEX9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEX9 | PPP1R13B | psi-mi:“MI:0915”(physical association) | 0.560 |
| GSTA5 | TEX9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TXNDC9 | TEX9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEX9 | CCHCR1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEX9 | NXF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEX9 | NOL4 | psi-mi:“MI:0914”(association) | 0.530 |
| DISC1 | AP4M1 | psi-mi:“MI:0914”(association) | 0.530 |
| CCDC148 | SCGB2A1 | psi-mi:“MI:0914”(association) | 0.350 |
| CDK5RAP2 | PDHX | psi-mi:“MI:0914”(association) | 0.350 |
| SYCE1 | RABGAP1L | psi-mi:“MI:0914”(association) | 0.350 |
| CEP128 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| PCM1 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CEP135 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| SPICE1 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CEP63 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| TEX9 | NOL4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (58): TEX9 (Affinity Capture-MS), CCDC112 (Affinity Capture-MS), NOL4L (Affinity Capture-MS), NOL4 (Affinity Capture-MS), TEX9 (Two-hybrid), TEX9 (Proximity Label-MS), TEX9 (Proximity Label-MS), TEX9 (Proximity Label-MS), TEX9 (Proximity Label-MS), TEX9 (Proximity Label-MS), NOL4 (Affinity Capture-MS), NOL4L (Affinity Capture-MS), CCDC112 (Affinity Capture-MS), TEX9 (Affinity Capture-MS), GOLGA2 (Two-hybrid)
ESM2 similar proteins: A0JMA8, A0MZ66, A0MZ67, A1A5P5, A4IGC3, A5WW21, B3DLE8, H2MTR9, P70302, P84903, Q08DR9, Q0P4J3, Q13586, Q16206, Q28IH8, Q2TAA8, Q3KR99, Q4R6I5, Q5BIX7, Q5I033, Q5M8Y7, Q5RA03, Q5U245, Q5XG48, Q5XIR8, Q6GP65, Q6IP02, Q6IQY5, Q6NRK1, Q6NRW2, Q6NRX3, Q6P0R8, Q6P402, Q7T0S7, Q7Z3E5, Q8BXX9, Q8K2Q9, Q8K4I6, Q8MJK1, Q8N6V9
Diamond homologs: Q8N6V9, Q9D845
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
83 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 63 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2981 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:56365671:G:GG | donor_gain | 1.0000 |
| 15:56373440:GGC:G | acceptor_gain | 1.0000 |
| 15:56373500:TAATA:T | donor_gain | 1.0000 |
| 15:56373501:AATA:A | donor_gain | 1.0000 |
| 15:56373501:AATAG:A | donor_loss | 1.0000 |
| 15:56373502:ATA:A | donor_gain | 1.0000 |
| 15:56373502:ATAG:A | donor_loss | 1.0000 |
| 15:56373503:TA:T | donor_gain | 1.0000 |
| 15:56373503:TAG:T | donor_loss | 1.0000 |
| 15:56373504:AGT:A | donor_loss | 1.0000 |
| 15:56373505:G:GG | donor_gain | 1.0000 |
| 15:56373506:T:TC | donor_loss | 1.0000 |
| 15:56373507:AAG:A | donor_loss | 1.0000 |
| 15:56373508:AG:A | donor_loss | 1.0000 |
| 15:56383922:T:G | acceptor_gain | 1.0000 |
| 15:56388462:T:TA | acceptor_gain | 1.0000 |
| 15:56389313:T:G | acceptor_gain | 1.0000 |
| 15:56389316:A:AG | acceptor_gain | 1.0000 |
| 15:56389317:G:GG | acceptor_gain | 1.0000 |
| 15:56389317:GCCAA:G | acceptor_gain | 1.0000 |
| 15:56391241:A:AG | acceptor_gain | 1.0000 |
| 15:56391242:G:GG | acceptor_gain | 1.0000 |
| 15:56391242:GT:G | acceptor_gain | 1.0000 |
| 15:56391355:G:GT | donor_gain | 1.0000 |
| 15:56391397:GTT:G | donor_gain | 1.0000 |
| 15:56391834:T:G | acceptor_gain | 1.0000 |
| 15:56394833:GG:G | donor_gain | 1.0000 |
| 15:56394834:GG:G | donor_gain | 1.0000 |
| 15:56412407:GAGT:G | donor_gain | 1.0000 |
| 15:56412410:T:G | donor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000023636 (15:56344119 A>G), RS1000024274 (15:56395093 A>G), RS1000027518 (15:56308715 A>G), RS1000038527 (15:56261577 G>A), RS1000051844 (15:56423991 C>G,T), RS1000081094 (15:56430176 A>C), RS1000102824 (15:56439771 A>G), RS1000111862 (15:56261368 A>T), RS1000119776 (15:56305756 G>A,T), RS1000135877 (15:56436313 C>T), RS1000170264 (15:56305396 A>C,G), RS1000175712 (15:56391065 A>G), RS1000208409 (15:56436166 C>T), RS1000223830 (15:56275104 G>A), RS1000237738 (15:56272602 T>G)
Disease associations
OMIM: gene MIM:620935 | disease phenotypes: MIM:618948
GenCC curated gene-disease
Mondo (1): heterotaxy, visceral, 9, autosomal, with male infertility (MONDO:0030070)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
24 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002183_9 | Relative hand skill in reading disability | 4.000000e-06 |
| GCST002595_8 | Clozapine-induced agranulocytosis | 9.000000e-07 |
| GCST004602_211 | Mean corpuscular volume | 5.000000e-11 |
| GCST004621_77 | Red cell distribution width | 3.000000e-15 |
| GCST004630_160 | Mean corpuscular hemoglobin | 2.000000e-09 |
| GCST006804_40 | Red cell distribution width | 9.000000e-14 |
| GCST008962_7 | Hematology traits | 1.000000e-08 |
| GCST008962_8 | Hematology traits | 2.000000e-08 |
| GCST90002390_414 | Mean corpuscular hemoglobin | 2.000000e-31 |
| GCST90002392_427 | Mean corpuscular volume | 3.000000e-37 |
| GCST90002396_634 | Mean reticulocyte volume | 6.000000e-31 |
| GCST90002397_256 | Mean spheric corpuscular volume | 2.000000e-28 |
| GCST90002403_481 | Red blood cell count | 3.000000e-10 |
| GCST90002404_364 | Red cell distribution width | 1.000000e-39 |
| GCST90020024_485 | A body shape index | 2.000000e-09 |
| GCST90020024_487 | A body shape index | 3.000000e-11 |
| GCST90020025_127 | Waist-to-hip ratio adjusted for BMI | 3.000000e-09 |
| GCST90020025_129 | Waist-to-hip ratio adjusted for BMI | 1.000000e-11 |
| GCST90020025_130 | Waist-to-hip ratio adjusted for BMI | 4.000000e-08 |
| GCST90020027_633 | Waist-hip index | 9.000000e-10 |
| GCST90020027_635 | Waist-hip index | 1.000000e-11 |
| GCST90020027_636 | Waist-hip index | 1.000000e-08 |
| GCST90020029_293 | Waist circumference adjusted for body mass index | 5.000000e-12 |
| GCST90020029_296 | Waist circumference adjusted for body mass index | 1.000000e-09 |
EFO canonical traits (9, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009902 | handedness |
| EFO:0009188 | Red cell distribution width |
| EFO:0004527 | mean corpuscular hemoglobin |
| EFO:0004348 | hematocrit |
| EFO:0004509 | hemoglobin measurement |
| EFO:0010701 | mean reticulocyte volume |
| EFO:0004305 | erythrocyte count |
| EFO:0007789 | BMI-adjusted waist circumference |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
36 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression | 6 |
| Cyclosporine | decreases expression, decreases methylation, increases expression | 3 |
| perfluorooctane sulfonic acid | decreases expression | 2 |
| Vorinostat | affects cotreatment, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| sotorasib | affects cotreatment, increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | decreases expression | 1 |
| arsenite | affects expression | 1 |
| sodium arsenite | affects methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | increases expression, affects cotreatment | 1 |
| jinfukang | decreases expression, affects cotreatment, increases expression | 1 |
| incobotulinumtoxinA | increases expression | 1 |
| trametinib | affects cotreatment, increases expression | 1 |
| NVP-BKM120 | affects cotreatment, increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Azathioprine | decreases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Clorgyline | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Quercetin | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): heterotaxy, visceral, 9, autosomal, with male infertility